You just read:

Novartis Pharmaceuticals Canada Inc. receives Health Canada approval for Ultibro™ Breezhaler®, a once-daily dual bronchodilator for COPD

News provided by

Novartis Pharmaceuticals Canada Inc.

Jan 13, 2014, 02:36 EST